North Carolina Needs to Produce More of Its Own Feed Grains

Feb 21, 2019

By John Hart

North Carolina State University Agricultural Economist Dr. Nicholas Piggott continues to emphasize the importance of North Carolina producing more of its own feed grains to meet the demands of the state’s livestock industry.

It’s a message he recently delivered to the Ag Development Forum during the Southern Farm Show at the State Fairgrounds in Raleigh. The North Carolina feed grain deficit currently averages around 50 percent: That is the state must import about half of the grain needed to feed hogs, chickens, and turkeys in North Carolina while producing the rest within the state.

Estimates peg the need for feed for North Carolina hogs, chickens and turkeys at roughly 310 million bushels per year. In 2018, the state produced about 154,000,000 bushels of its own feed grain, importing the rest. Piggott says producing more feed grain locally is better for both North Carolina livestock producers and North Carolina grain producers. Efforts to increase North Carolina feed grain production was the reason the North Carolina Feed Grain Initiative was launched in 2012 with funding support from Smithfield Foods.

Source: ncsu.edu

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.